Chandra Ganjoo, Group Chief Executive Officer at Trivitron Healthcare, unfolded the intricate dynamics of the medical technology (MedTech) sector. She opened up about the technological leaps, personalized healthcare demands, and strategic collaborations that drive recent growth.
Ms. Ganjoo sheds light on strategies employed by Indian MedTech companies for affordability, innovations catering to rural healthcare needs, and the global aspirations of the sector. As she delves into emerging trends and the transformative impact of ‘Make in India,’ a nuanced understanding of MedTech’s trajectory emerges.
Image Source: Shutterstock
India Business & Trade: What are the key factors driving the growth of the medical technology (medtech) sector in recent years?
Chandra Ganjoo: The medical technology (MedTech) sector’s recent growth hinges on several key factors. Technological advancements have empowered innovative diagnostics, treatments, and patient care. Increased demand for personalized healthcare solutions drives research and development, enhancing precision medicine and patient outcomes. Collaborations across sectors, including partnerships between MedTech firms and healthcare providers, foster novel solutions and efficient healthcare delivery.
Regulatory reforms and policies encouraging innovation and market access fuel industry growth, prompting investment and market expansion. Additionally, the pandemic accelerated telemedicine adoption, and modern research, creating opportunities for remote monitoring and virtual care, further propelling MedTech sector advancement. These factors are playing a major role in revolutionizing patient care.
India Business & Trade: What strategies are Indian MedTech companies employing to ensure the affordability of healthcare solutions?
Chandra Ganjoo: Indian MedTech companies are implementing several strategies to ensure the affordability of healthcare solutions, primarily driven by the unique healthcare challenges and economic conditions in the country. One key approach involves leveraging innovation and technology to develop cost-effective medical devices and diagnostic tools. Companies are investing in research and development to create solutions that are not only advanced but also budget-friendly.
Many MedTech firms are forming alliances with academic institutions, government bodies, and international organizations to access resources, share knowledge, and streamline the development process.
Furthermore, a focus on localized manufacturing helps cut production costs. Indian MedTech companies are increasingly establishing manufacturing facilities within the country, benefiting from lower production expenses and favourable regulatory environments.
Additionally, embracing digital health solutions is a significant strategy. Telemedicine and remote monitoring technologies enhance accessibility to healthcare services for all, which reduces the overall cost of healthcare delivery.
India Business & Trade: How is the MedTech industry addressing the unique healthcare needs of rural India?
Chandra Ganjoo: The MedTech industry is innovatively addressing rural India’s healthcare needs through tailored solutions to bridge the accessibility gap. Telemedicine platforms, leveraging mobile technology, connect rural patients with healthcare professionals, enabling remote consultations and diagnostic support by investing in IVD, portable diagnostic tools, such as handheld ultrasound devices and point-of-care testing kits, facilitate quick and accurate assessments even in remote areas where infrastructure is limited.
To tackle the challenge of transportation, companies are developing drones and mobile clinics equipped with essential medical devices to deliver supplies and medical assistance to remote regions efficiently.
MedTech firms are also collaborating with local healthcare providers to train personnel in utilizing these technologies effectively. Furthermore, affordable and user-friendly devices specifically designed for rural settings are being developed, considering factors like ease of use, durability, and cost-effectiveness. Initiatives focus on raising awareness about preventive healthcare practices through mobile apps and community outreach programs. Through these concerted efforts, the MedTech industry aims to democratize healthcare access, ensuring that rural populations in India receive timely and quality medical support despite geographical constraints.
India Business & Trade: What strategies are MedTech companies using to penetrate the global healthcare market?
Chandra Ganjoo: MedTech companies are employing several strategic approaches to break into the global healthcare market. Firstly, they’re prioritizing innovation, focusing on developing cutting-edge technologies like AI, IoT, and telemedicine. These advancements enhance patient care, streamline operations, and attract the attention of healthcare providers worldwide. Collaboration is another key strategy. MedTech firms are partnering with healthcare providers, research institutions, and even other tech companies. These collaborations help in refining products, gaining access to new markets, and leveraging expertise across various domains.
Adapting to regulatory landscapes is crucial. Companies invest in understanding and complying with diverse international regulations. This ensures smooth market entry and acceptance in different regions, overcoming barriers related to compliance and safety standards.
Lastly, strategic mergers and acquisitions play a significant role. These strategies collectively empower MedTech companies to navigate the complexities of the global healthcare market, fostering growth and facilitating better access to innovative healthcare solutions worldwide.
India Business & Trade: What are the emerging trends in medical device manufacturing and production processes?
Chandra Ganjoo: In the vibrant landscape of medical device manufacturing, several emerging trends are reshaping the industry. One notable trend is the increasing emphasis on healthcare at home, where devices like nebulizers, insulin delivery systems, and glucose monitors seamlessly integrate with electronic medical records and telemedicine platforms. This not only enhances patient convenience but also provides valuable data for informed clinical decision-making. Another transformative trend is the rise of 3D printing in producing medical equipment, set to reach a market value of US$ 4.5 billion by 2026. This technology allows local manufacturing, reducing dependence on imported devices and enabling on-site production of customized surgical equipment, implants, and prosthetics.
The integration of Artificial Intelligence (AI) and 5G technologies is revolutionizing medical device capabilities.
Genomic medicine is advancing, utilizing genomic information to tailor care plans through machine learning and AI. This approach not only expedites treatment but also enhances understanding of various medical disorders, leading to more efficient alternatives.
Device connectivity, facilitated by software like medical devices (SaMD), empowers patients by providing access to their medical data. This trend aligns with stringent government regulations aimed at safeguarding patient privacy as new devices enter the market.
India Business & Trade: How ‘Make in India’ is reshaping India’s MedTech sector?
Chandra Ganjoo: “Make in India” has significantly reshaped India’s MedTech sector by fostering a conducive environment for domestic manufacturing and innovation. The initiative has led to the development of state-of-the-art manufacturing infrastructure, enabling the production of high-quality medical devices. It has attracted both domestic and international investments, fostering collaborations that bring in advanced technologies and expertise.
The streamlined regulatory processes and supportive policies under this have facilitated faster approvals for new medical devices, encouraging research and development. This has resulted in a surge of innovation, with companies introducing cutting-edge technologies in diagnostics, imaging, and healthcare delivery systems.
Furthermore, the emphasis on skill development and training programs has created a skilled workforce, enhancing the sector’s overall efficiency.
Chandra Ganjoo is the Executive Director & Group Chief Executive Officer (Group CEO) of Trivitron Healthcare. She has been a pillar of strength to Trivitron handling several roles starting from Sales, Marketing, Branding & Corporate Communication, Cost Controller, Human Resources Management, & many more, right from 1999. Before joining Trivitron, Chandra had worked with Group 4 Securitas before shifting her domain to Healthcare Industry.
